Seung-Hwan Shin

发表

Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia

Inho Kim, Sung-Soo Yoon, Jae‐Ho Yoon, 2014, Thrombosis and Haemostasis.

Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1–RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1–RUNX1T1

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2021, Cancers.

WT1 measurable residual disease assay in AML who underwent allogeneic hematopoietic stem cell transplantation; optimal time points, threshold, and candidates.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, European journal of haematology.

Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Annals of Hematology.

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes

Yoo-Jin Kim, Yong-Rim Kwon, Silvia Park, 2019, Blood research.

Comparison of transplant‐specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2018, European journal of haematology.

The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, The Korean journal of internal medicine.

Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Blood research.

A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Cancers.

Recent advances in treatment of aplastic anemia

J. Lee, Seung-Hwan Shin, Sung Eun Lee, 2014, The Korean journal of internal medicine.

Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2020, American journal of hematology.

Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Annals of Hematology.

Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Cancers.

Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2013, International Journal of Hematology.

A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML)

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Therapeutic advances in hematology.

Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response.

H. Yhim, E. Song, Seung-Hwan Shin, 2012, Leukemia research.

Role of pretransplant anti‐thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndrome

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, European journal of haematology.

Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, Annals of Hematology.

Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy

H. Yhim, C. Min, Seung-Hwan Shin, 2013, International Journal of Hematology.

The optimal immunosuppressive therapy for aplastic anemia

J. Lee, Seung-Hwan Shin, J. W. Lee, 2013, International Journal of Hematology.

The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Annals of Hematology.

Non‐myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, European journal of haematology.

Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2021, Bone Marrow Transplantation.

Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients.

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2021, Transplantation and cellular therapy.

Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes.

Yoo-Jin Kim, Inho Kim, Sung‐Eun Lee, 2012, Leukemia research.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, European journal of haematology.

Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma

Jae‐Ho Yoon, C. Min, Sung‐Eun Lee, 2013, Immune network.

Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2021, Therapeutic advances in hematology.

Comparison of myeloablative (CyTBI, BuCy) versus reduced-intensity (FluBu2TBI400) peripheral blood stem cell transplantation in acute myeloid leukemia patients with pre-transplant low WT1 expression.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2015, Blood research.

Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2018, Bone Marrow Transplantation.

Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome

Jongtae Lee, D. Yim, Yoo-Jin Kim, 2015, Journal of Hematology & Oncology.

Equivalent Outcome of Autologous Stem Cell Transplantation and Reduced Intensity Conditioning Stem Cell Transplantation in Acute Myeloid Leukemia Patients with t(8;21)

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, Acta Haematologica.

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Blood research.

Outcomes of haploidentical stem cell transplantation using total body irradiation (600 cGy) and fludarabine with ATG in adult patients with severe aplastic anemia: A prospective phase II study.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.

Yoo-Jin Kim, Jae‐Ho Yoon, Jung-Ho Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA‐matched sibling donor

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2021, American journal of hematology.

Comparable Outcomes Between Unrelated and Haploidentical Stem Cell Transplantation in Adult Patients With Severe Aplastic Anemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Transplantation.

Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, Leukemia & lymphoma.

Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2014, Hematological oncology.

BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core‐binding‐factor‐positive AML

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, European journal of haematology.

Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic Prediction Model for Second Allogeneic Stem‐Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single‐Center Report

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2018, Clinical lymphoma, myeloma & leukemia.

Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts

Yoo-Jin Kim, Jae‐Ho Yoon, Dong-Wook Kim, 2016, Oncotarget.

Geriatric assessment predicts non-fatal toxicities and survival for intensively treated older adults with AML.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Blood.

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia.

Tae Woo Kim, B. Cho, Jae‐Ho Yoon, 2018, International Journal of Stem Cells.

CD161(+) T cells as predictive markers for acute graft-versus-host disease.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable long‐term outcomes after reduced‐intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high‐risk acute lymphoblastic leukemia in complete remission

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, American journal of hematology.

Influence of ex vivo purging with CliniMACS CD34+ selection on outcome after autologous stem cell transplantation in non‐Hodgkin lymphoma

Seung-Hwan Shin, Jae-Ho Yoon, Seok Lee, 2014, British journal of haematology.

Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of elderly de novo acute myeloid leukemia treated by a risk‐adapted approach based on age, comorbidity, and performance status

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, American journal of hematology.

Superior transplantation outcomes of 8/8‐matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, European journal of haematology.

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia

Tae Woo Kim, B. Cho, Jae‐Ho Yoon, 2018, International journal of stem cells.

Bone Marrow Plasma Cell Assessment before Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Yoo-Jin Kim, Jae‐Ho Yoon, J. Lee, 2014, BioMed research international.

Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Bone Marrow Transplantation.

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Annals of Hematology.

A VEGFR-3 Antagonist Increases IFN-γ Expression on Low Functioning NK Cells in Acute Myeloid Leukemia

Jae‐Ho Yoon, Ji Yoon Lee, W. Min, 2013, Journal of Clinical Immunology.

ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma

D. Dingli, C. Min, S. Yahng, 2023, NPJ precision oncology.

Response and dynamics of renal function for transplant-eligible multiple myeloma patients who were treated with novel agent: The CAREMM-2201 study.

Yaeni Kim, C. Min, S. Yahng, 2022, Transplantation and cellular therapy.

Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Frontiers in Oncology.

Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study

C. Min, S. Yahng, Y. Jeon, 2023, Journal of Cancer Research and Clinical Oncology.

Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2017, Oncotarget.

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

J. W. Lee, H. Kim, S. Lee, 2016, Bone Marrow Transplantation.

Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma

Yoo-Jin Kim, Jae‐Ho Yoon, Jung-Ho Kim, 2015, Annals of Hematology.

Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, International Journal of Hematology.

Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203).

Y. Jeon, Seung-Hwan Shin, S. Park, 2023, Journal of cancer research and clinical oncology.

Genetic–pathologic characterization of myeloproliferative neoplasms

Joonhong Park, Seungok Lee, Yonggoo Kim, 2016, Experimental & Molecular Medicine.

A VEGFR-3 Antagonist Increases IFN-γ Expression on Low Functioning NK Cells in Acute Myeloid Leukemia

Ji Yoon Lee, W. Min, Hee‐Je Kim, 2013, Journal of Clinical Immunology.

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

S. Lee, Y. Kim, Y. Kim, 2015, Bone Marrow Transplantation.

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2013, American journal of hematology.

Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1.

B. Cho, Yoo-Jin Kim, K. Eom, 2024, Bone marrow transplantation.